Increased plasma amyloid-β 42 protein in sporadic inclusion body myositis

ISSN： 0001-6322

Source： Acta Neuropathologica, Vol.118, Iss.3, 2009-09, pp. : 429-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dysferlin is a newly identified binding partner of AβPP and it co-aggregates with amyloid-β42 within sporadic inclusion-body myositis (s-IBM) muscle fibers

By Cacciottolo Mafalda Nogalska Anna D’Agostino Carla Engel W. Askanas Valerie

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 781-783

Springer Publishing Company

Access to resources Recommend Favorite

Update on sporadic inclusion body myositis

By Hohlfeld Reinhard

Brain, Vol. 134, Iss. 11, 2011-11 ,pp. : 3141-3145

Oxford University Press

Access to resources Recommend Favorite

TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies

By Kuiperij H. Abdo Wilson Engelen Baziel Schelhaas H. Verbeek Marcel

Acta Neuropathologica, Vol. 120, Iss. 6, 2010-12 ,pp. : 825-826

Springer Publishing Company

Access to resources Recommend Favorite

Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis

By Sancricca Cristina

Neurological Sciences, Vol. 32, Iss. 5, 2011-10 ,pp. : 841-847

Springer Publishing Company

Access to resources Recommend Favorite

Long-term observational study of sporadic inclusion body myositis

By Benveniste Olivier

Brain, Vol. 134, Iss. 11, 2011-11 ,pp. : 3176-3184

Oxford University Press

Access to resources Recommend Favorite